In this rule, CMS is finalizing remaining proposals from the Medicare Advantage (MA) and Prescription Drug Plans final rule published June 2020, including those related to Special Needs Plans, Part D Coverage Gap Discount Program, opioid misuse and abuse, and the PACE program. Some provisions are effective in March and others will take effect in 2022.
